What happened
Uttar Pradesh police carried out an operation after a train chase in which two criminals were shot. The Uttar Pradesh police response presents the action as a law-and-order response to suspects linked to serious criminal activity.
India’s drug regulator approved Wegovy for treatment in adults with metabolic dysfunction-associated steatohepatitis-related liver disease. The approval makes it the first glucagon-like peptide-1 (GLP-1) medicine cleared in India for that use.
The Prime Minister flagged off what is described as India’s first hydrogen-powered train on the Jind-Sonipat route. The release highlights the train’s zero-emission character and its significance for domestic railway innovation.
Why the middle two developments matter more for UPSC
The Wegovy approval matters because it links medicine regulation, non-communicable disease care, and the growing use of GLP-1 drugs beyond obesity treatment. The hydrogen train matters because it connects railway modernisation with decarbonisation and indigenous technology development.
Related current affairs
- Quality control framework for Ayurvedic medicines: regulatory provisions, testing labs and pharmacopoeial standards
- Integration of AYUSH in national health systems
- Delhi Cabinet clears implementation of Central govt. scheme to phase out old, polluting commercial vehicles
- Wegovy approved for fatty liver disease
- Government amends Drugs Rules, 1945 to strengthen regulation of high alcohol-containing drug formulations